BackCRISPR Therapeutics AG Overview

CRISPR Therapeutics AG Total Revenue

Revenue analysis for CRSP.

Quarterly Revenue

$1.46M

As of Mar 2026

Annual Revenue (TTM)

$4.10M
↓ 88.64% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin